Importantly, such growth factors play important roles in the growth and survival of cancer cells at all stages of progression and are strongly associated with aggressive prostate cancer [40,44], suggesting that the relevance of APP may not be limited to androgen-responsive tumours. This evidence concerns the gene APP and prostate carcinoma.